|
|
|
Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Anti-aging Research > Chemotherapy >
Iressa (gefitinib)
Iressa (gefitinib, ZD 1839)
Related Topics:
News & Research:
-
Iressa Has Little Effect on Advanced Breast Cancer - Doctor's Guide,
12/13/05
-
Gefitinib (Iressa) as Second-Line Therapy in Patients With Advanced
Non-Small-Cell Lung Cancer: Presented at WCLC - Doctor's Guide, 7/5/05
- FDA
Limits Use of Iressa for Non-Small Cell Lung Cancer - Medscape, 6/17/05
-
AstraZeneca Announces US Label Change for Iressa (Gefitinib) and New
Distribution - Doctor's Guide, 6/17/05
-
Gefitinib Fails to Improve Survival in Patients with Advanced Non-Small-Cell
Lung Cancer - Doctor's Guide, 5/18/05
-
Failed Lung Cancer Drug May Fight Breast Tumors - HealthDay, 5/16/05
-
Clinical Trial of Gefitinib for Advanced Lung Cancer Closes Early -
Doctor's Guide, 4/19/05
-
Why Some Lung Cancers Stop Responding To Tarceva And Iressa - Science Daily, 2/25/05
- FDA Statement On Iressa - Science Daily, 12/24/04
- Iressa Fails to Prolong Survival in Lung Cancer Clinical Trial - Medscape, 12/20/04
- Gefitinib (Iressa) Active against Advanced Colorectal Cancer - Doctor's Guide, 11/18/04
- Gefitinib (Iressa) Active against Advanced Colorectal Cancer - Doctor's Guide, 11/12/04
- Advanced Non-Small Cell Lung Cancer Survival With Gefitinib Comparable to First Line Chemotherapy - Doctor's Guide, 9/7/04
- Gefitinib Demonstrates Efficacy for Treatment of Bronchioloalveolar Lung Cancer - Doctor's Guide, 6/7/04
- Gefitinib Promising New Drug for Treatment of Non-Small Cell Lung Cancer - Doctor's Guide, 5/14/04
- Three Factors Influence Prognosis of Advanced Non-small Cell Lung Cancer Treated with Gefitinib - Doctor's Guide, 4/30/04
- American Society Of Clinical Oncology Recommends Gefitinib (Iressa, ZD1839) in Lung Cancer Treatment Guidelines' Update - Doctor's Guide, 2/2/04
- Gefitinib (Iressa, Zd1839) Demonstrates Early Promise in Advanced Breast Cancer - Doctor's Guide, 12/5/03
- Oral Gefitinib Results in Radiographic Disease Regression and Symptom Improvement in Patients with Non-Small-Cell Lung Cancer - Doctor's Guide, 10/27/03
- Gefitinib Helpful in Non-Small Cell Lung Cancer - Medscape, 10/21/03
- Gefitinib (Iressa) Shown to Prolong Survival, Improve Quality of Life in Women with Recurrent Metastatic Breast Cancer - Doctor's Guide, 9/29/03
- Significant Clinical Benefit Seen with Gefitinib in Advanced Non-Small Cell Lung Cancer - Doctor's Guide, 8/21/03
- New Data Support Gefitinib (Iressa, ZD1839) As Efficacious Anti-Cancer Agent In Non-Small Cell Lung Cancer - Doctor's Guide, 8/14/03
- Gefitinib (IRESSA, ZD1839) Demonstrates Clinical Activity In A Variety Of Tumours - Doctor's Guide, 6/2/03
- FDA Approves Iressa (Gefitinib), New Treatment For Non-Small-Cell Lung Cancer - Doctor's Guide, 5/5/03
- Drug [Iressa] Linked To 124 Deaths In Japan - CBS News, 1/10/03
- Biologic Agent [ZD1839 (Iressa)] May Benefit Some Breast Cancer Patients - Doctor's Guide, 12/13/02
- ZD 1839 (Iressa) with Standard Chemotherapy Does Not Improve Outcome in Advanced NSCLC - Doctor's Guide, 10/23/02
Related Sites:
70524
|
